UNSPSC 51314337: Chlorpheniramine/ephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE501. This VA Drug Class (RE501) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT.

UNSPSC 51314337 Chlorpheniramine/ephedrine is a Commodity code that in recent state and local procurement activity encompasses direct purchase of pharmaceutical products, including naloxone, generic multi-source pharmaceuticals, and over-the-counter medications for health systems, emergency response, and state health agency programs. The issuing bodies span county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances administering on behalf of state and local governments (Minnesota Multistate Cooperative Purchasing Alliance serving state facilities and local jurisdictions including Oregon). The work solicited includes direct procurement of finished pharmaceutical products for quarterly or annual delivery to public health facilities, cooperative purchasing framework agreements for generic pharmaceuticals through authorized wholesalers, and market-intelligence gathering to evaluate direct-to-manufacturer prescription program feasibility as an alternative to traditional pharmacy benefit manager and wholesaler channels.

Recent activity shows geographic spread across Florida, Texas, and the Upper Midwest with cooperative purchasing extending nationwide. Representative opportunities include Seminole County's IFB60459723LAS, an IFB posted June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline and quarterly deliveries to the Seminole County Community Health Building in Sanford; the Texas Health and Human Services Commission's RFI HHS0017013, posted April 3, 2026, seeking vendor capabilities for a direct-to-manufacturer prescription program to evaluate alternatives to existing pharmacy benefit manager arrangements; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products, posted January 20, 2026, with a March 26, 2026 proposal deadline and contract awards effective July 1, 2026, requiring vendors to maintain relationships with authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, Morris & Dickson) and meet cGMP and Drug Supply Chain Security Act compliance standards.